Jordan vs Low income (World Bank): Treatment success rate for patients treated for MDR-TB
Jordan
100.0%
in 2022
Low income (World Bank)
82.0%
in 2022
Jordan rank
1st
Low income (World Bank) rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Jordan
- Low income (World Bank)
How they compare
Jordan currently reports 100.0% against 82.0% in Low income (World Bank), a difference of 18.0%.
That makes Jordan's figure about 1.2 times Low income (World Bank)'s.
The two have swapped places 10 times across 19 shared years of data; in 2002 it was Jordan ahead.
Jordan ranks 1st and Low income (World Bank) ranks 1st of 163 countries.
Across the 3 decades both report, Jordan averaged higher in 2 and Low income (World Bank) in 1.
Head to head by decade
| Decade | Jordan | Low income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 58.2% | 55.5% | 2.7% | Jordan |
| 2010s | 71.3% | 67.8% | 3.5% | Jordan |
| 2020s | 77.7% | 80.7% | 3.0% | Low income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Jordan or Low income (World Bank)?
- Jordan, at 100.0% against 82.0% in Low income (World Bank) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Jordan and Low income (World Bank)?
- 18.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Low income (World Bank)?
- 19 years are reported by both, from 2002 to 2022.
- How do Jordan and Low income (World Bank) rank globally for treatment success rate for patients treated for mdr-tb?
- Jordan ranks 1st and Low income (World Bank) ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.